Abcam agreement expands gene catalogue
07 August 2007
Abcam, the bioscience company that markets antibodies via its own online catalogue, has entered an agreement with Alabama-based Open Biosystems which will see Open sell Abcam's primary antibodies alongside its own libraries of cDNA, ORF and shRNA clones. The agreement creates the world's most extensive resource of genetic content for the analysis of gene function.
Customers will use the advanced gene search tool at Open's website to query by gene symbol or accession to bring up an index of all of the matched content available to study a particular gene. Matched products will be shipped together within 48 hours of order receipt.
Jonathan Milner, Abcam's chief executive, said: “We are enthusiastic to be working alongside Open Biosystems and I believe this agreement will allow both companies to take the lead in this exciting part of the market.”
|
Relevant Companies
For more Company information and share price data click below:
|